TRANSCENTA-B (06628) Stock Price, News, Quotes-Moomoo

HK Stock MarketDetailed Quotes

06628 TRANSCENTA-B

Watchlist

0.620
0.0000.00%

Market Closed Jan 17 16:08 CST

269.03MMarket Cap-0.68P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Press Release: Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results
Dow JonesAug 29, 2024 02:31 ET
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results
PR NewswireAug 29, 2024 02:31 ET
Express News | Transcenta - Hy Loss RMB133.7 Mln
ReutersAug 28, 2024 08:03 ET
Express News | Transcenta Holding Limited H1 Revenue RMB 4.6 Million
ReutersAug 28, 2024 08:02 ET
Express News | Transcenta Holding - Yining Zhao Tendered His Resignation as Chairman
ReutersJun 7, 2024 05:42 ET
Express News | Transcenta Holding - Xueming Qian Appointed as Chairman
ReutersJun 7, 2024 05:41 ET

Comments

Christine Kho

Feb 15, 2023 23:28

bottom

$TRANSCENTA-B (06628.HK)$
bottom

Christine Kho

Feb 15, 2023 20:10

high success rate

$TRANSCENTA-B (06628.HK)$ backed by Lilly and Temasek, high success rate for Claudin 18.3

aiden_cole

Oct 9, 2021 07:04

$TRANSCENTA-B (06628.HK)$ On October 9, the CDE website showed that The application for clinical trial of MBOS TST005 injection was accepted by the Food and Drug Administration, and the indication is solid tumor. TST005 is the second bi-functional anti-PD-L1 and TGF-β trap fusion protein to initiate a global clinical study.

Heat List

Overall

No Data

Investment Theme

Pharmaceutical Companies

Intraday+1.08%